関連する実験動画

Updated: Sep 10, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

LGI3は,GEMIN6/AURKB軸を通じたTFE3再編成性腎臓細胞がんの進行を促進する

Junxiao Liu^1,2, Huayi Feng³, Zhuang Xiong¹

¹Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.

|August 23, 2025

まとめ

レウシンに富んだリピートLGIファミリーメンバー3 (LGI3) は,オーロラBキナーゼを促進するGEMIN6を安定させることで,攻撃的なTFE3-再編成性腎臓細胞癌 (TFE3- RCC) を誘発する. LGI3,GEMIN6,またはAURKBをターゲットにすることで,TFE3-RCCに対する新しい治療法を提供することができます.

科学分野:

腫瘍学
分子生物学
遺伝学

背景:

TFE3再構成性腎臓細胞癌 (TFE3- RCC) は,予後が悪い攻撃性である.
TFE3- RCCの腫瘍形成の分子要因は完全に理解されていません.

研究の目的:

TFE3-RCCにおけるTFE3融合タンパク質のダウンストリームターゲットを特定する.
TFE3-RCCの進行におけるLGI3のメカニズムを解明する.
LGI3経路を標的とした治療戦略を評価する.

主な方法:

ルシフェラーゼレポーターは,TFE3がLGI3プロモーターに結合することを確認する.
細胞の増殖,移動,侵入の検査
タンパク質の相互作用を研究するためのウエスタン・ブロッティングとウビキチネーションの測定法.
オルガノイドと細胞ラインの薬物感受性アッセイ.

主要な成果:

LGI3はTFE3融合タンパク質の直接的な転写標的である.
LGI3は,TFE3-RCC細胞の増殖,移動,侵入を促進する.
LGI3はGEMIN6のユビキチン化を阻害し,オーロラBキナーゼ (AURKB) mRNAの成熟を増加させる.
LGI3,GEMIN6,AURKBはヒトのTFE3-RCC組織で上位調節されている.
GEMIN6やAURKBを標的とした薬は,TFE3-RCCの増殖を in vitroやオーガノイドで抑制した.

結論:

LGI3は,LGI3- GEMIN6- AURKB軸を介して作用する,TFE3- RCCの主要な腫瘍発生因子である.
この経路は,TFE3-RCCにおける新しい治療的脆弱性を表しています.
GEMIN6またはAURKBをターゲットにすると,TFE3-RCCの治療には有望である.

さらに関連する動画

Translational Orthotopic Models of Glioblastoma Multiforme

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

関連する概念動画

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.